
INTRODUCTION
The supreme council of health in the Kingdom of Bahrain is pleased to announce the hosting of the “From Genes to Treatment Symposium," which will take place in the Kingdom of Bahrain on 23 February 2025, at the Diplomat Radisson Blu Hotel, with the presence of HE Lieutenant-General Dr. Shaikh Mohammed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health.
The Supreme Council of Health, in collaboration with Mobility Health Consultants, an event organizer, is putting on the From Genes to Treatment Symposium, a cutting-edge scientific and educational event. This event will focus on the essential role of pharmacogenomics in modern medicine and the inspiration of drug development.
The objective of this event is to provide physicians, pharmacists, and other healthcare professionals with a platform to extensively discuss the most recent developments in pharmacogenomics and personalized medicine.
Location
Timings | Speaker | Subject |
---|---|---|
07:30 - 08:00 | Registration | |
08:00 - 08:20 | Dr. Mariam Bu Sehail | Impact of Precision Medicine on PGX Application: How to Shift Towards Personalized Medicine in Inuencing the Current Medical Management Practice |
08:20 - 08:40 | Dr. Razan El Melik | How can Pharmacogenomic Support your Clinical Practice? (Virtual) |
08:40 - 09:00 | Discussion | |
09:00 - 09:15 | Opening Ceremony Part 1 | |
09:15 - 09:25 | Dr Jameela Alsalman | Bahrain Experience: The First Successful CRISPR-Based Sickle Cell Treatment |
09:25 - 09:15 | Prof. Sir Munir Pir Mohamed | Pharmacogenomics: Current Status and Future Perspectives |
09:45 - 09:25 | Opening Ceremony Part 2 | |
10:00 - 09:45 | Exhibition Opening & Coee Break | |
10:30 - 10:50 | Dr. Mohammed Essa | Experience of KSA: Success of the First Gene Therapy for Thalassemia |
10:50 - 11:20 | Prof. Fowzan AlKuraya | Druggable Genome: Human Genomics Inspiring Drug Development |
11:20 - 11:40 | Dr. Laila Abu Esba | A Critical Review of Evidence on SMA Disease Modifying Therapies, A Value Assessment |
11:40 - 11:50 | Discussion | |
11:50 - 12:05 | Discussion | |
12:05 - 12:25 | Dr. Anas Hamad | Pharmacogenetics: A Pathway to Cost Eective Targeted Healthcare |
12:25 - 12:45 | Dr. Fatema Marhoon | PGx Outcome of Bahraini Genome Project |
12:45 - 13:05 | Dr. Abdulrahman Sharaf | Pharmacogenomics: Bridging the Gap Between Genetics and Drug Response |
13:05 - 13:00 | Discussion | |
13:20 - 14:20 | Lunch Break | |
14:20 - 14:40 | Dr. Muneer Mahdi | Redene Asthma Rescue Therapy (Sponsored by AstraZeneca) |
14:20 - 14:40 | Dr. Anas Hamad | Harnessing Innovation in Glioma Care: A Multidisciplinary Approach (Sponsored by Servier) |
14:20 - 14:40 | Dr. Samih Al Qawlaq | Enabling PGx Proling with Innium Arrays (Sponsored by Al Zahrawi) |
14:40 - 15:00 | Dr. Hasan Fadhul | Avoiding Re-hospitalization: A place for Long Acting Injection (Sponsered by Lundbeck) |
14:40 - 15:00 | Dr. Burhanuddin Al Awadhi | Pharmcogenomics and the Future of Customised Medicine |
14:40 - 15:00 | Dr. Hassan Frookh | Semaglutide in Cardio-Kidney-Metabolic Disease: A Multi-Organ |
15:00 - 04:00 | Wrap up & Recommendations and Closure |